GABAPENTIN
- Product NDC
- 62207-926
- 11-digit product format
- 622070926
- Labeler code
- 62207
- Product ID
- 62207-926_eca48cc3-0a88-7c06-e053-2a95a90aa850
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Granules India Limited
- Application
- ANDA075360
- Marketing category
- ANDA
- Marketing start
- 2021-09-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62207-926-49 | GABAPENTIN | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 2 |
| 62207-926-54 | GABAPENTIN | 30 in 1 BOTTLE | CAPSULE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62207-926 | GABAPENTIN CAPSULE [GRANULES INDIA LIMITED] | 2 | Legacy NDC, 2 package rows | 20221105_bda0a0db-693b-b1e6-e053-2a95a90a5ce1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62207-926-49 | 62207092649 | 1000 CAPSULE in 1 BOTTLE (62207-926-49) | 1000 capsule | 2021-09-01 | 0000-00-00 | No | No | Current |
| 62207-926-54 | 62207092654 | 30 CAPSULE in 1 BOTTLE (62207-926-54) | 30 capsule | 2021-09-01 | 0000-00-00 | No | No | Current |